Apple's CareKit offers software platform for health apps

Apple has unveiled CareKit, a new software framework designed to help developers enable people to actively manage their own medical conditions.

iPhone apps using CareKit make it easier for individuals to keep track of care plans and monitor symptoms and medication; providing insights that help people better understand their own health, according to the company.

“We’re thrilled with the profound impact ResearchKit has already had on the pace and scale of conducting medical research, and have realized that many of the same principles could help with individual care,” said Jeff Williams, Apple’s chief operating officer. “We believe that giving individuals the tools to understand what is happening with their health is incredibly powerful, and apps designed using CareKit make this a reality by empowering people to take a more active role in their care.” 

CareKit will be released as an open source framework next month allowing the developer community to continue building on the first four modules designed by Apple, that include: 

  • Care Card helps people track their individual care plans and action items, such as taking medication or completing physical therapy exercises. Activities can automatically be tracked and entered using sensors in Apple Watch or iPhone;
  • Symptom and Measurement Tracker lets users easily record their symptoms and how they’re feeling, like monitoring temperature for possible infections or measuring pain or fatigue. Progress updates could include simple surveys, photos that capture the progression of a wound or activities calculated by using the iPhone’s accelerometer and gyroscope, like quantifying range of motion;
  • Insight Dashboard maps symptoms against the action items in the Care Card to easily show how treatments are working; and
  • Connect makes it easy for people to share information and communicate with doctors, care teams or family members about their health and any change in condition.

“With ResearchKit, we quickly realized the power of mobile apps for running inexpensive, high-quality clinical studies with unprecedented reach,” said Ray Dorsey, MD, David M. Levy Professor of Neurology at the University of Rochester Medical Center. “We hope that CareKit will help us close the gap between our research findings and how we care for our Parkinson’s patients day-to-day. It’s opening up a whole new opportunity for the democratization of research and medicine.”

Developers of health and wellness apps are working on several apps:

  • Sage Bionetworks and the University of Rochester are using CareKit to turn the mPower ResearchKit study into a valuable tool to help better inform patients about their condition and care providers about treatment.
  • The Texas Medical Center is designing apps to guide and support care pathways for its 8 million patients to improve their health through enhanced connectivity with their care teams.
  • Beth Israel Deaconess Medical Center will provide patients with more insight into their own chronic care management through home health monitoring devices that securely store data in HealthKit™.
  • One Drop is empowering people with a better approach to managing their diabetes.
  • Start, by Iodine, helps people on antidepressants understand if their medication is working for them or not, and helps their doctors deliver more informed care.
  • Glow will incorporate CareKit modules into its pregnancy app, Glow Nurture, to guide women through a healthier pregnancy.
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.